Pharmacy
Of those payments, about $4.7 billion were related to research while $2.8 billion were non-research payments.
Customers pay a monthly service fee, which is often covered by insurance companies and Medicare Part D plans.
The bill, known as the Support for Patients and Communities Act passed the House by a decisive majority of 396 to 14.
One new policy deems drug shortages an urgent public health crisis and seeks to have manufacturing sites deemed critical infrastructure.
A more concerted effort by pharmaceutical companies to drive medication adherence could help them increase their sales growth and margin profile.
Practice of PBMs being financially rewarded by drug manufacturers for setting higher prices needs to end, he says.
Kaiser Permanente found that hospitals can bolster patient satisfaction scores and increase revenue by decreasing levels of opioid prescriptions.
Even after taking into account manufacturer rebates, spending still increased more than 60 percent and the ranks of beneficiaries paying $2,000 out-of-pocket a year doubled, the Office of the Inspector General says.
Program is a crucial part of operations for hospitals that serve vulnerable populations because it offsets the high costs medications.
Brand drug manufacturers are delaying the development and entry of generics, federal officials say.